Targeting Oral Cancer (inbunden)
Fler böcker inom
Format
Inbunden (Hardback)
Språk
Engelska
Antal sidor
302
Utgivningsdatum
2016-03-14
Upplaga
1st ed. 2016
Förlag
Springer International Publishing AG
Medarbetare
Fribley, Andrew (ed.)
Illustratör/Fotograf
40 farbige Tabellen 40 farbige Abbildungen Bibliographie
Illustrationer
2 Illustrations, color; 36 Illustrations, black and white; X, 302 p. 38 illus., 2 illus. in color.
Dimensioner
263 x 181 x 23 mm
Vikt
1162 g
Antal komponenter
1
Komponenter
1 Hardback
ISBN
9783319276458

Targeting Oral Cancer

av Andrew Fribley
Inbunden,  Engelska, 2016-03-14
1163
Köp
Spara som favorit
  • Skickas från oss inom 10-15 vardagar.
  • Fri frakt över 249 kr för privatkunder i Sverige.
Finns även som
Visa alla 2 format & utgåvor
This book provides research-oriented care providers with up-to-date information on the oral cancer patient population, the ways in which we are treating them, and the scientific approaches being pursued in order to improve survival and reduce treatment-related morbidity. The text is organized into three sections covering epidemiology and management, cancer development and biomarkers, and breaking developments and novel approaches for drug discovery. The first section includes discussion of the emerging role of HPV in oral cancer and explains the surgical, chemotherapy and radiation approaches to treatment. Aspects such as molecular progression, the role of cancer stem cells in tumor development, and the value of various biomarkers are then examined. The final section is devoted to the latest advances and covers, among other topics, current clinical trials, emerging drug targets, and targeting of the unfolded protein response and of mediators of coagulation.
Visa hela texten

Passar bra ihop

  1. Targeting Oral Cancer
  2. +
  3. Why We Get Sick

De som köpt den här boken har ofta också köpt Why We Get Sick av Benjamin Bikman (häftad).

Köp båda 2 för 1372 kr

Kundrecensioner

Har du läst boken? Sätt ditt betyg »

Recensioner i media

This title is useful in extending knowledge of the key aspects of the disease and would be ideal for those undertaking specific research at postgraduate level. Overall, this book is an informative read for those involved with oral cancers wishing to obtain up-to-date, well researched information. It is indeed a targeted resource to all aspects of this disease. (C. Whyte, British Dental Journal, Vol. 221 (8), October, 2016)

Övrig information

Andrew M. Fribley graduated with a BS from Central Michigan University, Mt. Pleasant, MI and in 2005 gained his PhD from the University of Michigan, Ann Arbor, MI (Program in Oral Health Sciences, University of Michigan School of Dentistry). He then worked as a Post-Doctoral Research Fellow in the University of Michigan, School of Medicine, Department of Biological Chemistry and the Howard Hughes Medical Institute In 2010, Dr. Fribley was appointed Assistant Professor of Pediatrics at Wayne State University (Division of Hematology/Oncology), Detroit, MI. He is also an Associate in the Department of Otolaryngology at Wayne State University and a Scientific Member of the Karmanos Cancer Institute (Molecular Therapeutics Program). Dr. Fribley has received various awards, including the William J. Gies Award for the most outstanding manuscript published in the Journal of Dental Research (2003) and the Edward Hatton Award (First Prize, Senior Category) from the American Association of DentalResearch and the International Association of Dental Research (2004). Since 2012 he has been a member of the Fellowships Committee of the American Association of Dental Research. He has published original articles in a variety of leading peer-reviewed journals.

Innehållsförteckning

Epidemiology and Management: Epidemiology.- Emerging Role of HPV.- Management of Oral Cancer. Development and Biomarkers: Molecular Progression and Signaling.- Stem Cells and Tumor Development.- Prognostic/Predictive Biomarkers.- EIF4e as Biomarker and Target. Breaking Developments and New Drug Discovery: Current Clinical Trials.- Emerging Drug Targets.- Targeting the UPR.- Targeting Meditators of Coagulation.- Resveratrol Pre-Sensitizing.- Academic High Throughput Drug Discovery.

Du kanske gillar